Literature DB >> 1763894

Leber's hereditary optic neuropathy and complex I deficiency in muscle.

N G Larsson1, O Andersen, E Holme, A Oldfors, J Wahlström.   

Abstract

We investigated a family with Leber's hereditary optic neuropathy in which affected individuals were homoplasmic for the point mutation of the NADH-dehydrogenase 4 gene of mitochondrial DNA, described by Wallace and colleagues in 1988. The proband had bilateral optic atrophy, tremor, dystonia, and sharply defined lesions in the putamen on magnetic resonance images. Optic atrophy was found in another 3 of 13 investigated relatives on the maternal side. Additional neurological signs were found but only in patients with optic neuropathy. The morphological appearance and the respiratory chain function of muscle tissue were investigated in the proband, his mother, and 3 siblings. Polarographic measurements revealed complex I deficiency in the 5 investigated subjects. Morphological changes of mitochondria were found in 4 of these subjects. There was no decrease in complex I activity measured as NADH ferricyanide reductase or rotenone-sensitive NADH cytochrome c reductase activities. In other cases with complex I deficiency, good agreement between polarographic and spectrophotometric measurements was found. This study showed that there is decreased activity of complex I of the respiratory chain in muscle and that cerebral striatal lesions occur in Leber's hereditary optic neuropathy with the NADH-dehydrogenase 4 gene point mutation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763894     DOI: 10.1002/ana.410300511

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

2.  Characterization of basal ganglia dysfunction in Leber 'plus' disease.

Authors:  C O Hanemann; H Hefter; G Schlaug; R J Seitz; H J Freund; R Benecke
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 3.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 4.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

5.  Compensatory elevation of complex II activity in Leber's hereditary optic neuropathy.

Authors:  M Y Yen; H C Lee; J H Liu; Y H Wei
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

6.  Weighing in on Leber hereditary optic neuropathy: effects of mitochondrial mass.

Authors:  Michio Hirano
Journal:  Brain       Date:  2014-02       Impact factor: 13.501

7.  Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia.

Authors:  A S Jun; I A Trounce; M D Brown; J M Shoffner; D C Wallace
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

8.  Cerebellar ataxia in patients with Leber's hereditary optic neuropathy.

Authors:  I Funakawa; H Kato; A Terao; K Ichihashi; S Kawashima; T Hayashi; K Mitani; S Miyazaki
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

9.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 10.  Mitochondrial DNA sequence variation in human evolution and disease.

Authors:  D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.